116 related articles for article (PubMed ID: 1326261)
1. Non-cytopathic infection of rhabdomyosarcoma cells by coxsackie B5 virus.
Argo E; Gimenez B; Cash P
Arch Virol; 1992; 126(1-4):215-29. PubMed ID: 1326261
[TBL] [Abstract][Full Text] [Related]
2. Evolution of coxsackie B virus during in vitro persistent infection: detection of protein mutations using two-dimensional polyacrylamide gel electrophoresis.
McLaren J; Argo E; Cash P
Electrophoresis; 1993; 14(1-2):137-47. PubMed ID: 8385003
[TBL] [Abstract][Full Text] [Related]
3. Persistence of coxsackievirus B4 infection in rhabdomyosarcoma cells for 30 months. Brief report.
Frisk G; Lindberg MA; Diderholm H
Arch Virol; 1999; 144(11):2239-45. PubMed ID: 10603178
[TBL] [Abstract][Full Text] [Related]
4. Analysis of protein synthesis by two-dimensional gel electrophoresis in T cells persistently infected with coxsackie B virus.
Gimenez B; Amarasekera D; Argo E; Cash P
Electrophoresis; 1995 Mar; 16(3):317-21. PubMed ID: 7607163
[TBL] [Abstract][Full Text] [Related]
5. Cytolytic replication of coxsackievirus B2 in CAR-deficient rhabdomyosarcoma cells.
Polacek C; Ekström JO; Lundgren A; Lindberg AM
Virus Res; 2005 Nov; 113(2):107-15. PubMed ID: 15964091
[TBL] [Abstract][Full Text] [Related]
6. Detection of picornavirus genomic and template RNA strands by a novel semi-nested polymerase chain reaction-technique and agarose-gel electrophoresis.
Gow J; Cash P; Behan W; McGarry F; Simpson K; Behan P
Electrophoresis; 1995 Mar; 16(3):338-40. PubMed ID: 7541748
[TBL] [Abstract][Full Text] [Related]
7. [Susceptibility of RD-9H8 cells derived from RD cells to enteroviruses and its application for measuring neutralizing antibodies against coxsackievirus group B].
Yanagihara T; Matsumoto I; Kawana R
Kansenshogaku Zasshi; 1992 Apr; 66(4):484-9. PubMed ID: 1320655
[TBL] [Abstract][Full Text] [Related]
8. Studies on human immunodeficiency virus-induced cytopathic effects: use of human rhabdomyosarcoma (RD) cells.
Srinivasan A; Goldsmith CS; York D; Anand R; Luciw P; Schochetman G; Palmer E; Bohan C
Arch Virol; 1988; 99(1-2):21-30. PubMed ID: 3355373
[TBL] [Abstract][Full Text] [Related]
9. Slow Infection due to Lowering the Amount of Intact versus Empty Particles Is a Characteristic Feature of Coxsackievirus B5 Dictated by the Structural Proteins.
Turkki P; Laajala M; Stark M; Vandesande H; Sallinen-Dal Maso H; Shroff S; Sävneby A; Galitska G; Lindberg AM; Marjomäki V
J Virol; 2019 Oct; 93(20):. PubMed ID: 31375587
[TBL] [Abstract][Full Text] [Related]
10. Establishment of a cell line persistently infected with bovine herpesvirus-4 by use of a recombinant virus.
Donofrio G; Cavirani S; van Santen VL
J Gen Virol; 2000 Jul; 81(Pt 7):1807-14. PubMed ID: 10859387
[TBL] [Abstract][Full Text] [Related]
11. Mapping of the RD phenotype of the Nancy strain of coxsackievirus B3.
Lindberg AM; Crowell RL; Zell R; Kandolf R; Pettersson U
Virus Res; 1992 Jul; 24(2):187-96. PubMed ID: 1326828
[TBL] [Abstract][Full Text] [Related]
12. Persistent infection of human microvascular endothelial cells by coxsackie B viruses induces increased expression of adhesion molecules.
Zanone MM; Favaro E; Conaldi PG; Greening J; Bottelli A; Perin PC; Klein NJ; Peakman M; Camussi G
J Immunol; 2003 Jul; 171(1):438-46. PubMed ID: 12817028
[TBL] [Abstract][Full Text] [Related]
13. Influence of neopterin and 7,8-dihydroneopterin on the replication of Coxsackie type B5 and influenza A viruses.
Bratslavska O; Platace D; Miklasevics E; Fuchs D; Martinsons A
Med Microbiol Immunol; 2007 Mar; 196(1):23-9. PubMed ID: 16868770
[TBL] [Abstract][Full Text] [Related]
14. Persistent replication of herpes simplex virus type 1 in JOK-1 cells.
Thiele K; Mittnacht S; Kirchner H
J Gen Virol; 1989 Jul; 70 ( Pt 7)():1907-11. PubMed ID: 2544670
[TBL] [Abstract][Full Text] [Related]
15. Regulation of viral persistence in human glioblastoma and rhabdomyosarcoma cells infected with coronavirus OC43.
Collins AR; Sorensen O
Microb Pathog; 1986 Dec; 1(6):573-82. PubMed ID: 2854604
[TBL] [Abstract][Full Text] [Related]
16. Microinjected Coxsackie B1 virus does not replicate in HEp-2 cells.
Modalsli KR; Bukholm G; Mikalsen SO; Degré M
Virology; 1991 Dec; 185(2):888-90. PubMed ID: 1660207
[TBL] [Abstract][Full Text] [Related]
17. Antibody capture radioimmunoassay (MACRIA) for coxsackievirus B4 and B5-specific IgM.
Morgan-Capner P; McSorley C
J Hyg (Lond); 1983 Jun; 90(3):333-49. PubMed ID: 6306097
[TBL] [Abstract][Full Text] [Related]
18. The mammalian cell-virus relationship. VI. Sustained infection of HeLa cells by Coxsackie B3 virus and effect on superinfection.
CROWELL RL; SYVERTON JT
J Exp Med; 1961 Feb; 113(2):419-35. PubMed ID: 13696665
[TBL] [Abstract][Full Text] [Related]
19. Altered receptor specificity of coxsackievirus B3 after growth in rhabdomyosarcoma cells.
Reagan KJ; Goldberg B; Crowell RL
J Virol; 1984 Mar; 49(3):635-40. PubMed ID: 6321753
[TBL] [Abstract][Full Text] [Related]
20. In vitro (1)H NMR studies of RD human cell infection with echovirus 11.
Akhtar SN; Singh RK; Jadegoud Y; Dhole TN; Ayyagari A; Nagana Gowda GA
NMR Biomed; 2007 Jun; 20(4):422-8. PubMed ID: 17013981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
